The diagnosis came in the way these diagnoses often do. A blood test that had been ordered for something else came back with markers that did not quite belong. A second test confirmed them. The consultant explained, with practised gentleness, that the body’s immune system had been doing something it should not be doing — turning, in some quiet way, on the tissues it was meant to be protecting. The condition had a name, a prognosis, and a treatment plan. The person sitting across the desk was told that there was nothing they had done to cause it, nothing they could have done to prevent it, and not much they could do beyond following the medication regime and attending the appointments.

This is the standard arc, and most of it is broadly correct. Autoimmune diseases are not caused by failures of behaviour, and the immunological mechanisms involved are real and well-characterised. But the part of the conversation that almost never happens, in the consultant’s office, is the one about what role chronic stress, unresolved trauma, and sustained nervous system dysregulation may have played in the conditions under which the autoimmune process began to express, and what role addressing those substrates might play in the trajectory of the condition over the years that follow.

This piece is not a claim that trauma causes autoimmune disease. The literature is more careful than that, and so are we. It is, instead, an account of what the growing research on the trauma–autoimmunity connection actually shows, and what people living with these conditions can usefully do with that information.

What the Research Currently Says

The link between adverse life experience and later autoimmune presentation has been studied more rigorously over the past fifteen years than in any previous period. The headline findings, drawn from large cohort studies in the United States, Sweden, and the United Kingdom, are consistent enough to be worth taking seriously.

Adults who report adverse childhood experiences — the well-known ACE study findings, replicated in multiple populations — show meaningfully elevated rates of autoimmune disease in adulthood, with the elevation rising in proportion to the number of categories of adverse experience reported. The effect is most pronounced for conditions including rheumatoid arthritis, lupus, multiple sclerosis, type 1 diabetes, inflammatory bowel disease, and some thyroid autoimmunities, but the pattern extends across most of the autoimmune family.

Adults who have experienced significant single-event trauma — combat, sexual assault, major accident — show similar elevated rates, with the effect strongest in the years immediately following the event but persisting for decades. Cohort studies of post-traumatic stress disorder consistently find autoimmune disease at higher rates than in matched controls.

The mechanism is no longer entirely mysterious. Sustained activation of the hypothalamic–pituitary–adrenal axis, chronic alteration of cortisol rhythm, persistent inflammation markers, dysregulation of immune system signalling, and the cumulative wear of allostatic load on regulatory systems together create the conditions under which an autoimmune process can express in a person whose genetic substrate makes the condition possible. The genetics are still required. Trauma does not create the susceptibility. It contributes to the conditions under which the susceptibility expresses.

Why This Matters for People Already Living With the Disease

The disease, once present, is its own thing. The medication is doing what medication does. The flares come and go on their own logic. None of this gets dismissed by attention to the substrate.

What does change, often substantially, is the trajectory. Many people living with autoimmune disease, in our clinical experience and in an increasing body of research, find that conditions which had been managed but not stabilised become meaningfully more stable when the underlying trauma and nervous system dysregulation are addressed in parallel with the medical treatment. Flare frequency decreases. Medication doses sometimes reduce, with consultant supervision. The unpredictability of the condition, which is often as taxing as the symptoms themselves, becomes more predictable as the autonomic baseline steadies.

This is not a cure narrative. It is a co-treatment narrative. The medical care continues, and in most cases must continue. What is added is care for the substrate that the medical pathway alone has not been designed to address.

What This Kind of Work Looks Like

The work that produces results in this combined picture has several features. It is somatic and body-aware, not because the body needs to be retrained but because the autonomic patterns that have contributed to the chronic load need to be approached at the level they actually operate. It is trauma-specific where indicated, addressing the specific experiences that the nervous system has not yet integrated. It is paced carefully — autoimmune patients have already been carrying significant physiological load, and the work has to respect that load rather than add to it.

The modalities that we have found most useful in this category, in combination with continuing medical care: somatic experiencing and similar autonomic-focused approaches, breathwork calibrated to vagal toning, biofeedback for nervous system regulation, gentle yoga or movement therapy adapted for the specific condition, EMDR where there is identifiable trauma to process, and where appropriate, the use of hyperbaric oxygen therapy as a supportive intervention for inflammation modulation.

What is less useful in isolation: intense psychological work without somatic accompaniment, which can deepen the integration but does not always shift the autonomic substrate. High-intensity wellness protocols, which can overwhelm a system already compromised by chronic inflammation. Generic stress management, which is not calibrated to the trauma–autoimmunity specifics. The clinical art is in pacing and combining, and the work tends to ask for time rather than intensity.

The Conversation With the Treating Team

A common worry, for people considering this kind of parallel work, is whether their consultant or rheumatologist will see it as an attempt to substitute alternative treatment for medical care. In our experience, treating teams are increasingly comfortable with their patients adding trauma-informed and somatic work alongside medical management, particularly when the patient is clear that medication and follow-up will continue and that the additional work is supportive rather than replacement.

We routinely communicate, with patient consent, with treating consultants in the UK and Europe, both to share what we are doing and to coordinate care where appropriate. The intention is not to position our work in opposition to medical care. It is to add a layer that the medical pathway is not structured to provide.

A Note for People Who Have Wondered About This

There is often a private hypothesis that people living with autoimmune disease have already formed about the role of their own life experience in the condition. They will not always have said it aloud, particularly to medical professionals who have, with the best intentions, told them that the disease is not their fault. The two things are not in conflict. It is possible for an autoimmune disease to be not one’s fault and also to have arisen under conditions that have something to do with what the nervous system has been carrying.

If the hypothesis has been quietly present, the work that addresses it is available. It will not undo the disease, in most cases. It will, often, change what living with it feels like, and may change the trajectory over the years ahead. The first inquiry can be made whenever the time feels right.